Few Asthma Patients Are on Recommended Inhaler Regimen
Despite updated guidelines, only 14.5% of adults with moderate to severe asthma are prescribed the SMART combination inhaler regimen.Â
Tag: Symbicort
Few Asthma Patients Are on Recommended Inhaler Regimen
Despite updated guidelines, only 14.5% of adults with moderate to severe asthma are prescribed the SMART combination inhaler regimen.Â
Read More
AstraZeneca Sets $35 Monthly Cap on Inhaler Costs
Starting June 1, eligible patients will pay no more than $35 per month for all AstraZeneca US inhaled respiratory medicines.
Read More
Severe Asthma ManagementÂ
Severe asthma patients account for as much as 60% of all asthma healthcare costs, and proper management of severe disease is essential.
Read More
FDA Approves First Symbicort Generic to Treat Asthma and COPD
The US FDA approved the first Symbicort generic inhalation aerosol from Mylan Pharmaceuticals for the treatment of asthma and COPD.
Read More
FDA Clears Propeller Health Connectivity for Symbicort Inhaler
Propeller Health has received FDA 510(k) clearance to connect patients using the Symbicort Inhaler to its digital health platform.
Read MoreAsthma Therapy Symbicort Improved Lung Function
New data demonstrated that the maintenance combination asthma therapy, Symbicort (budesonide/formoterol fumarate dehydrate), provides a rapid, clinically significant bronchodilatory response.
Read More